157 related articles for article (PubMed ID: 32043627)
1. Proton Pump Inhibitor Use Before ICU Admission Is Not Associated With Mortality of Critically Ill Patients.
Shi L; Zhang D
J Clin Pharmacol; 2020 Jul; 60(7):860-866. PubMed ID: 32043627
[TBL] [Abstract][Full Text] [Related]
2. The Association of Proton Pump Inhibitors and QT Interval Prolongation in Critically Ill Patients.
Fan W; Liu H; Shen Y; Hong K
Cardiovasc Drugs Ther; 2024 Jun; 38(3):517-525. PubMed ID: 36625987
[TBL] [Abstract][Full Text] [Related]
3. A pragmatic assessment of proton pump inhibitors vs. histamine type 2 receptor antagonists on clinically important gastrointestinal bleeding and mortality when used for stress ulcer prophylaxis in the ICU.
Boyd C; Hassig T; MacLaren R
Pharmacotherapy; 2021 Oct; 41(10):820-827. PubMed ID: 34478588
[TBL] [Abstract][Full Text] [Related]
4. Administration of proton pump inhibitors in critically ill medical patients is associated with increased risk of developing Clostridium difficile-associated diarrhea.
Buendgens L; Bruensing J; Matthes M; Dückers H; Luedde T; Trautwein C; Tacke F; Koch A
J Crit Care; 2014 Aug; 29(4):696.e11-5. PubMed ID: 24674763
[TBL] [Abstract][Full Text] [Related]
5. Effect of Stress Ulcer Prophylaxis With Proton Pump Inhibitors vs Histamine-2 Receptor Blockers on In-Hospital Mortality Among ICU Patients Receiving Invasive Mechanical Ventilation: The PEPTIC Randomized Clinical Trial.
; Young PJ; Bagshaw SM; Forbes AB; Nichol AD; Wright SE; Bailey M; Bellomo R; Beasley R; Brickell K; Eastwood GM; Gattas DJ; van Haren F; Litton E; Mackle DM; McArthur CJ; McGuinness SP; Mouncey PR; Navarra L; Opgenorth D; Pilcher D; Saxena MK; Webb SA; Wiley D; Rowan KM
JAMA; 2020 Feb; 323(7):616-626. PubMed ID: 31950977
[TBL] [Abstract][Full Text] [Related]
6. Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients.
Barletta JF; Sclar DA
Crit Care; 2014 Dec; 18(6):714. PubMed ID: 25540023
[TBL] [Abstract][Full Text] [Related]
7. Leveraging a critical care database: selective serotonin reuptake inhibitor use prior to ICU admission is associated with increased hospital mortality.
Ghassemi M; Marshall J; Singh N; Stone DJ; Celi LA
Chest; 2014 Apr; 145(4):745-752. PubMed ID: 24371841
[TBL] [Abstract][Full Text] [Related]
8. Proton Pump Inhibitors Versus Histamine-2 Receptor Antagonists Likely Increase Mortality in Critical Care: An Updated Meta-Analysis.
Lee TC; Goodwin Wilson M; Lawandi A; McDonald EG
Am J Med; 2021 Mar; 134(3):e184-e188. PubMed ID: 32931766
[TBL] [Abstract][Full Text] [Related]
9. The efficacy and safety of acid suppressants for gastrointestinal bleeding prophylaxis in cardiac care unit patients.
Chen C; Liu H; Duan R; Wang F; Duan L
J Gastroenterol Hepatol; 2021 Aug; 36(8):2131-2140. PubMed ID: 33586808
[TBL] [Abstract][Full Text] [Related]
10. Pneumonia prevention in intubated patients given sucralfate versus proton-pump inhibitors and/or histamine II receptor blockers.
Grindlinger GA; Cairo SB; Duperre CB
J Surg Res; 2016 Dec; 206(2):398-404. PubMed ID: 27884335
[TBL] [Abstract][Full Text] [Related]
11. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit.
MacLaren R; Reynolds PM; Allen RR
JAMA Intern Med; 2014 Apr; 174(4):564-74. PubMed ID: 24535015
[TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitor use is not associated with cardiac arrhythmia in critically ill patients.
Chen KP; Lee J; Mark RG; Feng M; Celi LA; Malley BE; Danziger J
J Clin Pharmacol; 2015 Jul; 55(7):774-9. PubMed ID: 25655574
[TBL] [Abstract][Full Text] [Related]
13. Proton Pump Inhibitors Are Not Associated With Acute Kidney Injury in Critical Illness.
Lee J; Mark RG; Celi LA; Danziger J
J Clin Pharmacol; 2016 Dec; 56(12):1500-1506. PubMed ID: 27492273
[TBL] [Abstract][Full Text] [Related]
14. Cost-Effectiveness of Histamine
Hammond DA; Kathe N; Shah A; Martin BC
Pharmacotherapy; 2017 Jan; 37(1):43-53. PubMed ID: 27809338
[TBL] [Abstract][Full Text] [Related]
15. [Benefits and risks of stress ulcer prevention with proton pump inhibitors for critical patients: an observational cohort study with 1 972 patients].
Sun J; Wang B; Cao P; Zhu H; Lu K; Geng P; Tan D
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 May; 31(5):539-544. PubMed ID: 31198136
[TBL] [Abstract][Full Text] [Related]
16. Re-evaluating the Utility of Stress Ulcer Prophylaxis in the Critically Ill Patient: A Clinical Scenario-Based Meta-Analysis.
Reynolds PM; MacLaren R
Pharmacotherapy; 2019 Mar; 39(3):408-420. PubMed ID: 30101529
[TBL] [Abstract][Full Text] [Related]
17. Effects of daily treatment with acid suppressants for stress ulcer prophylaxis on risk of ventilator-associated events.
Li X; Klompas M; Menchaca JT; Young JG
Infect Control Hosp Epidemiol; 2020 Feb; 41(2):187-193. PubMed ID: 31818336
[TBL] [Abstract][Full Text] [Related]
18. Nocturnal Mean Arterial Pressure Rising Is Associated With Mortality in the Intensive Care Unit: A Retrospective Cohort Study.
Li J; Li R; Gao Y; Zhang J; Zhao Y; Zhang X; Wang G
J Am Heart Assoc; 2019 Oct; 8(19):e012388. PubMed ID: 31566067
[TBL] [Abstract][Full Text] [Related]
19. Comparative Effectiveness of Proton Pump Inhibitors vs Histamine Type 2 Receptor Blockers for Preventing Clinically Important Gastrointestinal Bleeding During Intensive Care: A Population-Based Study.
Lilly CM; Aljawadi M; Badawi O; Onukwugha E; Tom SE; Magder LS; Harris I
Chest; 2018 Sep; 154(3):557-566. PubMed ID: 29856970
[TBL] [Abstract][Full Text] [Related]
20. Proton pump inhibitors versus histamine-2 receptor blockers for stress ulcer prophylaxis in patients with sepsis: a retrospective cohort study.
Huang M; Han M; Han W; Kuang L
J Int Med Res; 2021 Jun; 49(6):3000605211025130. PubMed ID: 34182815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
